Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Beigene Ltd Ads (NQ: BGNE )

301.28 USD +12.06 (+4.17%)
Official Closing Price Updated: 4:27 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Beigene Ltd Ads

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Second- or Third-line Non-Small Cell Lung Cancer
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that a supplemental... 
From Business Wire News Releases
Stocks Showing Improving Market Leadership: Beigene Earns 83 RS Rating
Beigene sees its Relative Strength Rating move into the 80-plus level. 
From Investor's Business Daily
Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia
Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia 
From Business Wire News Releases
BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan
BeiGene Announces Closing of Collaboration with Novartis to Develop & Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan 
From Business Wire News Releases
Assembly Biosciences Foregoes Vebicorvir Registration Studies For Chronic Suppressive Therapy
Assembly Biosciences Inc(NASDAQ:ASMB)will not initiatePhase 3 studies of vebicorvir (VBR, or ABI-H0731) as a ... 
Tags Market News Hepatits A BGNE
From Benzinga
BeiGene Reports Fourth Quarter and Full Year 2020 Financial Results
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported recent business highlights,... 
From Business Wire News Releases
Stocks Showing Improving Market Leadership: Beigene Earns 84 RS Rating
Beigene shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84. 
From Investor's Business Daily
Week In Review: Yuanxin Raises $465 Million For Online Healthcare Company Miaoshou Doctor
Beijing Yuanxin Technology raised $465 million in a Series E round to support its online/offline healthcare operations, known as Miaoshou Doctor. The company's latest round was led jointly by Sequoia... 
Tags Market News Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists 
From Business Wire News Releases
BeiGene's US Application For BRUKINSA In A Type Of Lymphoma, Accepted For Review
The FDA has accepted for reviewBeiGene Ltd's(NASDAQ:BGNE) supplemental marketing application seeking approval ... 
Tags News Biotech FDA
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AMTI DFFN SESN
From Benzinga
BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia
BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia 
From Business Wire News Releases
Two Days Worth of News
The Sterling fell against the dollar after rising most of February, which boosted the indexes. 
Tags ETFs Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AVNS PLXP IBB
From Benzinga
bye bye BGNE and Mexichem
After a bull run for 5 days the Dow-Jones is down today. But as usual the index is only part of the picture. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Roll Call
The week ended with a disappointment in hiring levels which failed to back up lower unemployment numbers from earlier this week. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Stock Squeeze Remnants
Nokia remains in focus, the only major ADR gaining from the gamestoppers. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Week In Review: Matridx Raises $32 Million For AI/CRISPR-Cas Pathogen Metagenomics Diagnostic Devices
Matridx Biotech of Hangzhou closed a $32 million Series B round to support its pathogen metagenomics devices. GenFleet Therapeutics raised $16 million in a Series B+ round for clinical trials of its... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Freezing Friday
Today is a good day for being into non-US shares as well as homeland ones. 
Tags Stocks / Equities
From Blogs - TalkMarkets
BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma
BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma 
From Business Wire News Releases
Stand Back!
The crazy market continues, fed by newbie investors ganging up on short-sellers. 
Tags ETFs Stocks / Equities Commodities
From Blogs - TalkMarkets
Industrial Uncertainty
Healthcare is continuing its bipolar action. 
Tags Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags KRYS Small Cap AMTI
From Benzinga
Trade War Coming
There is a trade war coming between Germany and the USA because of rivalry on stimulus for the COVID epidemic. 
Tags Stocks / Equities
From Blogs - TalkMarkets
EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT® (Siltuximab for Injection) in China
EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) today announced that the Biologics License Application (BLA) for SYLVANT® (siltuximab for injection) was accepted by the China... 
From Business Wire News Releases
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 82 stocks hit new 52-week highs. Areas of Interest: PayPal Holdings (NASDAQ:PYPL) ... 
Tags RNLX FSLF SAII
From Benzinga
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MBIO BDSX DTIL
From Benzinga
3 Lesser-Known Biotech Stocks that are Surging
Biotechnology was one of the most popular sectors in 2020. The coronavirus pandemic drew attention to the sector due to the urgent need for COVID-19 testing supplies and a vaccine. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ZLAB NTRA STOK
From Benzinga
First Week of March 19th Options Trading For BeiGene (BGNE)
Investors in BeiGene Ltd (BGNE) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BGNE options chain... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.